Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000270694 corresponds to the proline-rich coiled-coil 2A pseudogene, which is a non-functional, processed or unprocessed copy of the protein-coding PRRC2A gene. Pseudogenes are classified based on their origin—they may result from gene duplication events or retrotransposition and typically lack the ability to encode a functional protein due to disruptive mutations or loss of regulatory elements[2][4][6]. PRRC2A (the parental gene) is involved in mRNA modification and oligodendroglial specification[1][5], but the pseudogene does not possess such functions. Pseudogenes are not considered therapeutic targets, do not encode receptors, enzymes, or other targetable proteins, and generally lack direct relevance to drug targeting, biomarker status, or disease causation, although in rare cases they may participate in gene regulation[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich coiled-coil 2A pseudogene (PRRC2A pseudogene).